Vanguard Capital Management
AVNS

Vanguard Capital Management’s Avanos Medical AVNS Stock Holding History

Vanguard Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.6M Buy
1,993,794
+21,829
+1% +$511K ﹤0.01% 1954
2026
Q1 		$27.6M Buy
+1,971,965
New +$26.6M ﹤0.01% 2171

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management's AVNS Position: Q2 2026 in Review

Vanguard Capital Management increased its Avanos Medical (AVNS) stake by 1.1% in Q2 2026, buying an estimated $511K and bringing the position to 1,993,794 shares worth $49.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1954.

Vanguard Capital Management first reported a position in AVNS in Q1 2026 and has held it in 2 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Vanguard Capital Management held 1,993,794 shares of Avanos Medical worth $49.6M as of Q2 2026.
  • Vanguard Capital Management bought 21,829 Avanos Medical shares in Q2 2026, an estimated $511K.
  • Avanos Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1954 holding.
  • Vanguard Capital Management first reported a position in Avanos Medical in Q1 2026 and has held it in 2 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.